These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26564224)

  • 1. Effect of norfloxacin therapy for acute, uncomplicated lower urinary tract infection on vaginal Candida prevalence.
    Rocha RM; Zanni PC; de Souza Bonfim-Mendonça P; Gimenes F; Alczuk SS; Svidzinski TI; Consolaro ME
    Int Urogynecol J; 2016 May; 27(5):773-80. PubMed ID: 26564224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study.
    Xu J; Schwartz K; Bartoces M; Monsur J; Severson RK; Sobel JD
    J Am Board Fam Med; 2008; 21(4):261-8. PubMed ID: 18612052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics.
    Pirotta MV; Garland SM
    J Clin Microbiol; 2006 Sep; 44(9):3213-7. PubMed ID: 16954250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F; Del Piano M; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S73-80. PubMed ID: 22955364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women.
    Gunther LS; Martins HP; Gimenes F; Abreu AL; Consolaro ME; Svidzinski TI
    Sao Paulo Med J; 2014; 132(2):116-20. PubMed ID: 24714993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic vaginal candidiasis after pivmecillinam and norfloxacin treatment of acute uncomplicated lower urinary tract infection.
    Menday AP
    Int J Antimicrob Agents; 2002 Oct; 20(4):297-300. PubMed ID: 12385688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does vaginal douching affect the type of candidal vulvovaginal infection?
    Shaaban OM; Abbas AM; Moharram AM; Farhan MM; Hassanen IH
    Med Mycol; 2015 Nov; 53(8):817-27. PubMed ID: 26129887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal pH and microbiota during fluconazole maintenance treatment for recurrent vulvovaginal candidosis (RVVC).
    Donders GG; Grinceviciene S; Ruban K; Bellen G
    Diagn Microbiol Infect Dis; 2020 Jun; 97(2):115024. PubMed ID: 32253071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of vulvovaginal candidiasis in pregnancy at three health centers in Burkina Faso.
    Sangaré I; Sirima C; Bamba S; Zida A; Cissé M; Bazié WW; Sanou S; Dao B; Menan H; Guiguemdé RT
    J Mycol Med; 2018 Mar; 28(1):186-192. PubMed ID: 28939305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
    Venugopal D; Husain K; Mustafa SA; Sabeen S
    J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.
    Guzel AB; Ilkit M; Burgut R; Urunsak IF; Ozgunen FT
    Mycopathologia; 2011 Jul; 172(1):25-36. PubMed ID: 21293929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations with asymptomatic colonization with Candida in women reporting past vaginal candidiasis: an observational study.
    Watson CJ; Fairley CK; Grando D; Garland SM; Myers SP; Pirotta M
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):376-9. PubMed ID: 23639675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvovaginal candidiasis among symptomatic women of childbearing age attended at a Medical Analysis Laboratory in Franceville, Gabon.
    Bignoumba M; Onanga R; Bivigou Mboumba B; Gafou A; Mouanga Ndzime Y; Lendamba RW; Mbombe Moghoa K; Kassa Kassa RF
    J Mycol Med; 2019 Dec; 29(4):317-319. PubMed ID: 31481349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Vulvovaginal Candidiasis among Lebanese Pregnant Women: Prevalence, Risk Factors, and Species Distribution.
    Ghaddar N; El Roz A; Ghssein G; Ibrahim JN
    Infect Dis Obstet Gynecol; 2019; 2019():5016810. PubMed ID: 31467477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.
    McClelland RS; Richardson BA; Hassan WM; Graham SM; Kiarie J; Baeten JM; Mandaliya K; Jaoko W; Ndinya-Achola JO; Holmes KK
    J Infect Dis; 2009 Jun; 199(12):1883-90. PubMed ID: 19456235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil.
    Lopes Consolaro ME; Aline Albertoni T; Shizue Yoshida C; Mazucheli J; Peralta RM; Estivalet Svidzinski TI
    Rev Iberoam Micol; 2004 Dec; 21(4):202-5. PubMed ID: 15709802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor.
    Nyirjesy P; Zhao Y; Ways K; Usiskin K
    Curr Med Res Opin; 2012 Jul; 28(7):1173-8. PubMed ID: 22632452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin].
    Ogouyèmi-Hounto A; Adisso S; Djamal J; Sanni R; Amangbegnon R; Biokou-Bankole B; Kinde Gazard D; Massougbodji A
    J Mycol Med; 2014 Jun; 24(2):100-5. PubMed ID: 24746421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can intrauterine contraceptive devices lead to VulvoVaginal Candidiasis (VVC) and Anemia in Iranian new users?
    Behboudi-Gandevani S; Imani S; Moghaddam-Banaem L; Roudbar-Mohammadi S
    Sex Reprod Healthc; 2015 Mar; 6(1):40-3. PubMed ID: 25637424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.